Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

ArriVent collapses on disappointing lung cancer data

More than half of the company’s value was wiped out by findings that appear to erase a chance to battle Johnson & Johnson and others for market share.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at biopharmadive.com →

More in Health & Medicine

The Future Is Universal Health Insurance

Employer-sponsored health insurance is rapidly deteriorating in the US. With premiums expected to increase by 11% next year, it’s time Americans embraced a universal public health insurance system…

More from Tuesday 6 October →